Singapore markets open in 4 hours 18 minutes

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4900+0.2300 (+7.06%)
As of 03:42PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.2600
Bid3.4700 x 3000
Ask3.4800 x 3100
Day's range3.3200 - 3.7000
52-week range2.7900 - 9.2500
Avg. volume4,099,325
Market cap1.381B
Beta (5Y monthly)2.14
PE ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.31
  • Zacks

    Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?

    Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

  • Motley Fool

    Why Amarin Stock Tumbled in November

    Shares of the cardiovascular disease specialist Amarin (NASDAQ: AMRN) lost approximately a quarter of their value during the month of November, according to data from S&P Global Market Intelligence. Rather, Amarin's stock appears to have simply followed the broader biotech space downward last month. Amarin's shares, in particular, were probably a victim of year-end tax-loss selling last month.

  • Motley Fool

    Why Amarin Stock Crushed the Market on Tuesday

    Shares of biotech Amarin (NASDAQ: AMRN) shot more than 3% higher on Tuesday. In a regulatory filing submitted after market hours on Monday, hedge fund Sarissa Capital Management revealed that as of Sept. 30, it held an 8.5 million share stake in Amarin. Activist investors like Sarissa Capital Management frequently take out small, anchor positions in companies to effect change and "unlock" purportedly dormant value in their shares.